Leash Bio

Leash Bio is a startup. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Leash Bio builds a proprietary, large-scale dataset of protein–molecule interactions by screening millions of compounds against hundreds of protein targets (claiming tens of billions of measurements) and uses those data to train machine learning models to design and test novel molecules for drug discovery.